Blinatumomab Significantly Enhanced Cytotoxicity and T-Cell Cytokine Secretion Against Burkitt Lymphoma (BL) and Primary Mediastinal B-Cell Lymphoma (PMBL)

Authors

Aradhana Awasthi, New York Medical CollegeFollow
Dina Edani, New York Medical College
Christeen Azmy, New York Medical College
Janet Ayello, New York Medical CollegeFollow
Mitchell S. Cairo, New York Medical CollegeFollow

Document Type

Abstract

Publication Date

9-2018

DOI

10.1111/bjh.15536

Journal Title

British Journal of Haematology

Department

Pediatrics

Second Department

Health Behavior and Community Health

Recommended Citation

Awasthi, A., Edani, D., Azmy, C., Ayello, J., & Cairo, M. S. (2018). Blinatumomab Significantly Enhanced Cytotoxicity and T-Cell Cytokine Secretion Against Burkitt Lymphoma (BL) and Primary Mediastinal B-Cell Lymphoma (PMBL). British Journal of Haematology, 182 (Suppl. 1), 67. https://doi.org/10.1111/bjh.15536